This is a one day “deep-dive” briefing on successfully sourcing pharmaceutical ingredients and developing sourcing partnerships in India & China.
Pharma sourcing from emerging markets has seen a meteoric rise in recent years with western companies tempted to source from emerging market “hotspots” to remain competitive in an increasingly price sensitive market.
The two countries that have unquestionably led the way are India and China - they have grown to be key players in sourcing competitively priced pharma ingredients, fully manufactured drugs, and increasingly are becoming world leaders in research and development, and innovation. However, sourcing from this new market comes with potentially catastrophic consequences if product quality and IP rights are compromised.
PharmaSource - India & China 2008 has been researched and produced to provide a concise, yet comprehensive overview of the regulatory and competitor landscapes coupled with reliable key market trends in relation to Pharma sourcing from both India and China. This one day briefing provides an essential source of unbiased information on achieving both a cost effective and safe emerging market sourcing strategy.
- Benchmark your emerging market sourcing strategies with leading experts, and learn from their experiences on sourcing from India and China
- Obtain detailed and practical guidance on mitigating the quality and safety risks of sourcing from emerging markets
- Receive comprehensive clarification and updates on the regulatory and compliance issues for Pharma sourcing
- Learn from leading country and regional experts on securing your intellectual property through robust protection strategies
For details, please visit
www.pharmasource-indiachina.com or contact:
CMPi Conferences
Ludgate House
245 Blackfriars Road
London SE1 9UY
United Kingdom